According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, all patients undergoing weight loss therapy should be monitored for mood disorders, depression, and suicidal ideation
Gastrointestinal symptoms: Some peptides, especially GLP-1 receptor agonists such as semaglutide or tirzepatide, can slow digestion, which may lead to nausea, vomiting, diarrhea, or constipation
The manufacturer, distributor, and retailer assume no liability for improper use, adverse reactions, or outcomes resulting from use of this product
Deficiency in healthy individuals is rare
A well-planned tirzepatide diet plan makes the transition much smoother
These compounds help your body break down and eliminate fat more efficiently